Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D3CG6E
|
|||
| Drug Name |
MB-66
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Herpes simplex virus infection [ICD-11: 1F00; ICD-10: B00; ICD-9: 54] | Phase 1 | [1] | |
| Human immunodeficiency virus infection [ICD-11: 1C62; ICD-9: 42] | Phase 1 | [2] | ||
| Company |
Mapp Biopharmaceutical
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02579083) Vaginal Antibody Safety Trial: Safety Study of Monoclonal Antibodies to Reduce the Vaginal Transmission of Herpes Simplex Virus (HSV) and Human Immunodeficiency Virus (HIV) (VAST). U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.